Article Text

PDF
Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy
  1. D Araújo-Vilar1,
  2. G Lattanzi2,
  3. B González-Méndez1,
  4. A T Costa-Freitas1,
  5. D Prieto3,
  6. M Columbaro2,
  7. E Mattioli2,
  8. B Victoria1,
  9. N Martínez-Sánchez1,
  10. A Ramazanova1,
  11. M Fraga5,
  12. A Beiras5,
  13. J Forteza5,
  14. L Domínguez-Gerpe1,
  15. C Calvo4,
  16. J Lado-Abeal1
  1. 1
    Thyroid and Metabolic Diseases Unit (UETeM.), Department of Medicine, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
  2. 2
    IGM-CNR Unit of Bologna c/o IOR, Bologna, Italy
  3. 3
    Department of Surgery, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, Spain
  4. 4
    Unit of Hypertension and Vascular Risk, Department of Internal Medicine, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, Spain
  5. 5
    Department of Pathology, School of Medicine, University of Santiago de Compostela, Santiago de Compostela, Spain
  1. Dr D Araújo-Vilar, UETeM, Department of Medicine, Facultade de Medicina, University of Santiago de Compostela, Rua de San Francisco s/n, 15782 Santiago de Compostela, Spain; david.araujo{at}usc.es

Abstract

Background: Type 2 familial partial lipodystrophy (FPLD2) is characterised by loss of fat in the limbs and buttocks and results from mutations in the LMNA gene.

Aim: To evaluate the role of several genes involved in adipogenesis in order to better understand the underlying mechanisms of regional loss of subcutaneous adipose tissue (scAT) in patients with FPLD2.

Methods: In total, 7 patients with FPLD2 and 10 healthy control participants were studied. A minimal model was used to calculate the insulin sensitivity (IS). scAT was obtained from abdomen and thigh by biopsy. Relative gene expression was quantified by real-time reverse transcription PCR in a thermal cycler. Prelamin A western blot analysis was carried out on scAT and prelamin A nuclear localisation was determined using immunofluorescence. Adipocyte nuclei were examined by electron microscopy.

Results: Patients with FPLD2 were found to have significantly lower IS. The expression of LMNA was similar in both groups. The expression of PPARG2, RB1, CCND3 and LPL in thigh but not in abdomen scAT was significantly reduced (67%, 25%, 38% and 66% respectively) in patients with FPLD2. Significantly higher levels of prelamin A were found in peripheral scAT of patients with FPLD2. Defects in the peripheral heterochromatin and a nuclear fibrous dense lamina were present in the adipocytes of patients with FPLD2.

Conclusions: In FPLD2 participants, prelamin A accumulation in peripheral scAT is associated with a reduced expression of several genes involved in adipogenesis, which could perturb the balance between proliferation and differentiation in adipocytes, leading to less efficient tissue regeneration.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.